PCM
BLUE

Price Capital Management’s bluebird bio BLUE Stock Holding History

Price Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-765
Closed -$1.76M – 26
2017
Q4 		$1.76M Buy
+765
New +$1.55M 0.61% 61
2015
Q2 		– Sell
-453
Closed -$708K – 29
2015
Q1 		$708K Buy
+453
New +$598K 0.44% 101

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Price Capital Management's BLUE Position: Q1 2018 in Review

Price Capital Management sold out of bluebird bio (BLUE) in Q1 2018, closing a stake of 765 shares — an estimated $1.76M sold.

Price Capital Management first reported a position in BLUE in Q1 2015 and held it in 2 quarters. The position peaked at $1.76M in Q4 2017. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.

  • Price Capital Management reported no remaining bluebird bio position as of Q1 2018 after selling out during the quarter.
  • Price Capital Management sold 765 bluebird bio shares in Q1 2018, an estimated $1.76M.
  • Price Capital Management first reported a position in bluebird bio in Q1 2015 and held it in 2 quarters.
  • Price Capital Management's bluebird bio position peaked at $1.76M in Q4 2017.
  • 303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.

Based on Price Capital Management's 13F filing for Q1 2018, filed 1 May 2018.